Methylation of MGMT Is Associated with Poor Prognosis in Patients with Stage III Duodenal Adenocarcinoma

Tao Fu; Anup Sharmab; Fei Xie; Yanliang Liu; Kai Li; Weiwei Wan; Stephen B. Baylin; Christopher L. Wolfgang; Nita Ahuja

doi:10.1371/journal.pone.0162929

Loading metrics

Open Access

Peer-reviewed

Research Article

Methylation of MGMT Is Associated with Poor Prognosis in Patients with Stage III Duodenal Adenocarcinoma

Tao Fu ,

* E-mail: futao1975@tom.com (TF); nahuja1@jhmi.edu (NA)

Affiliation Department of Gastrointestinal Surgery II, Key Laboratory of Hubei Province for Digestive System Disease, Renmin Hospital, Wuhan University, Wuhan, China

http://orcid.org/0000-0003-4713-7269

⨯
Anup Sharmab,

Affiliation Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
⨯
Fei Xie,

Affiliation Department of Gastrointestinal Surgery II, Key Laboratory of Hubei Province for Digestive System Disease, Renmin Hospital, Wuhan University, Wuhan, China
⨯
Yanliang Liu,

Affiliation Department of Gastrointestinal Surgery II, Key Laboratory of Hubei Province for Digestive System Disease, Renmin Hospital, Wuhan University, Wuhan, China
⨯
Kai Li,

Affiliation Department of Gastrointestinal Surgery II, Key Laboratory of Hubei Province for Digestive System Disease, Renmin Hospital, Wuhan University, Wuhan, China
⨯
Weiwei Wan,

Affiliation Department of Gastrointestinal Surgery II, Key Laboratory of Hubei Province for Digestive System Disease, Renmin Hospital, Wuhan University, Wuhan, China
⨯
Stephen B. Baylin,

Affiliation Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
⨯
Christopher L. Wolfgang,

Affiliation Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
⨯
Nita Ahuja

* E-mail: futao1975@tom.com (TF); nahuja1@jhmi.edu (NA)

Affiliations Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America, Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America, Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
⨯

Methylation of MGMT Is Associated with Poor Prognosis in Patients with Stage III Duodenal Adenocarcinoma

Tao Fu,
Anup Sharmab,
Fei Xie,
Yanliang Liu,
Kai Li,
Weiwei Wan,
Stephen B. Baylin,
Christopher L. Wolfgang,
Nita Ahuja

Published: September 19, 2016
https://doi.org/10.1371/journal.pone.0162929

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Methylation
Is the Subject Area "Methylation" applicable to this article?

Thanks for your feedback.
DNA methylation
Is the Subject Area "DNA methylation" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Colorectal cancer
Is the Subject Area "Colorectal cancer" applicable to this article?

Thanks for your feedback.
Gastrointestinal cancers
Is the Subject Area "Gastrointestinal cancers" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Chemoradiotherapy
Is the Subject Area "Chemoradiotherapy" applicable to this article?

Thanks for your feedback.
Adenocarcinoma
Is the Subject Area "Adenocarcinoma" applicable to this article?

Thanks for your feedback.